1458-19-1

Basic information

• Product Name: METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE
• Synonyms: METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE
• CAS NO: 1458-19-1
• Molecular Formula: C₆H₈N₄O₂
• Molecular Weight: 168.15
• Mol File: 1458-19-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE(1458-19-1)
• EPA Substance Registry System: METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE(1458-19-1)

Safety Data

• Hazardous Substances Data: 1458-19-1(Hazardous Substances Data)

Usage

General Description

Methyl 3,5-diaminopyrazine-2-carboxylate is a chemical compound with the molecular formula C7H10N4O2. It is an organic compound that is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceuticals. METHYL 3,5-DIAMINOPYRAZINE-2-CARBOXYLATE is also used in the field of organic chemistry and research as a starting material in the preparation of other complex organic compounds. It is a white to off-white powder with a molecular weight of 182.18 g/mol. Methyl 3,5-diaminopyrazine-2-carboxylate is considered to be stable under normal temperature and pressure, but should be stored and handled in a controlled environment to prevent any potential hazards.

Upstream product

• 1458-01-1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid methyl ester 

Downstream Products

• 135673-70-0 6-Acetyl-3,5-diamino-pyrazine-2-carboxylic acid methyl ester 
• 1135686-60-0 methyl 3,5-diamino-6-phenylpyrazine-2-carboxylate 
• 1345839-39-5 C₁₂H₁₃N₇O*ClH 
• 1345839-41-9 C₁₄H₁₃N₇O*ClH 
• 146940-41-2 Methyl 3,5-diamino-6-phenylethinylpyrazine-2-carboxylate 
• 39939-29-2 3,5-Diamino-pyrazinsaeure 
• 146940-45-6 6-(1-Hydroxybenzyl)amiloride 
• 146940-44-5 6-Benzoylamiloride 
• 135673-73-3 3,5-diamino-6-(α-hydroxybenzyl)-2-pyrazinecarboxylate 
• 135673-72-2 3,5-Diamino-6-benzoyl-pyrazine-2-carboxylic acid methyl ester 

Relevant articles and documents

Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA)

A known side-activity of the oral potassium-sparing diuretic drug amiloride is inhibition of the enzyme urokinase-type plasminogen activator (uPA, K i = 7 μM), a promising anticancer target. Several studies have demonstrated significant antitum

NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND

The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].